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Mesenchymal stem cells (MSCs) have become a critical addition to all facets of tissue engineering. While most in vitro research
has focused on their behavior in two-dimensional culture, relatively little is known about the cells’ behavior in three-dimensional
culture, especially with regard to their metabolic state. To evaluateMSC metabolism during twodimensionalculture, murine bone
marrow-derived MSCs were cultured for one week using twelve diﬀerent medium compositions, varying in both glucose and fetal
bovine serum (FBS) concentrations. The results indicate that glucose concentration was the more important factor in sustaining
cell growthandviability.Toevaluatemetabolicstateduringthree-dimensionalculture, MSCswere cultured foroneweek usingtwo
diﬀerent medium compositionsandtwo diﬀerent concentrations ofcollagengel matrix. The medium compositionsonlyvaried in
glucose concentration. The results indicate that glucose and extracellular matrix were signiﬁcant factors in the metabolic response
of the cells. However, cells cultured in low density collagen exhibited considerablecell death, likely because of physical contraction
of the collagen hydrogel which was not observed in the higher density collagen. These ﬁndings will be useful to the development
of in vitro cell culture models that properly mimic in vivo physiologicalprocesses.
1.Introduction
Tissue engineering integrates the application of engineering
and biological principles to study, design, develop, and
repair biological structures. It is an iterative, objective-
driven process which has spurred the production of artiﬁcial
skin [1–3] and led to advances in the development of
smooth muscle tissue [4, 5], synthetic blood vessels [6–
8], cardiac tissue analogues [9–11], renal tubules [12, 13],
intestinal segments [14,15],bladdersubstitutes[16–18],and
bone tissue scaﬀolds [19–21]. Long-term success of these
tissue-engineered therapies requires their biocompatibility
with the host tissue and the development of functionally
diﬀerentiated cells within the implanted tissue. Stem cells
are important to these applications because of their ability
to diﬀerentiate into various cell types.
Bone marrow-derived mesenchymal stem cells (MSCs)
are less controversial to obtain and easier to control
than embryonic stem cells [22]. But, all stem cells must
be subjected to various environmental cues in order to
diﬀerentiate into speciﬁc cell types. To date, the most
common method of controlling stem cell diﬀerentiation is
to implement physiologically relevant factor proteins and
molecular cues designed to take advantage of the natural
competence of the MSCs. This process has led to advances
in liver repair [23–28], islet cell regeneration [29–34],
bone augmentation [35–37], and spinal cord regeneration
[38–40].
While these advances are signiﬁcant to the ﬁeld, current
research is lacking in relation to the three-dimensional
culture of MSCs, their metabolic state, and how both of
theseconsiderationsmayaﬀecttheirterminaldiﬀerentiation.2 Stem Cells International
It is important to consider how cells will respond in three-
dimensionalculturecomparedwithtwo-dimensionalculture
because it has been shown that extracellular matrix interac-
tions cause many diﬀerent cellular reactions related to dif-
ferentiation, proliferation, growth,motility, and gene expres-
sion [41–49]. Additionally, because aerobic metabolism and
anaerobic metabolism are the primary means of deriving
energy for cells and because much more energy is derived
aerobically than anaerobically, it is reasonable to assume that
the prevailing metabolic state experienced by the cells will
have a signiﬁcant eﬀect on the terminal diﬀerentiation of
the stem cells. Evidence has shown that metabolic state can
inﬂuence both protein activation and protein conformation
[50, 51], both of which are crucial during cell diﬀerentiation.
This may also aﬀect the ability of growth factors and other
stimuli to induce the desired outcomes in vivo.
Consequently, the overall motivation of this series of
experimentswastoinvestigatethemetabolicstateofMSCsin
culture in response to variations in glucose and fetal bovine
serum (FBS) concentrations in both two-dimensional and
three-dimensional culture conditions.
2.Materialsand Methods
2.1. Two-Dimensional Cell Culture. Murine MSCs (ATCC
Number CRL-12424) were used for these experiments
(ATCC, Manassas, Va, USA). MSCs were cultured in
maintenance medium composed of glutamine-free Dul-
becco’s modiﬁcation of Eagle’s medium (DMEM) (90-113-
PB, Mediatech, Herndon, VA) supplemented with 10%
FBS (Invitrogen, Carlsbad, Calif, USA), 1% penicillin-
streptomycin (10mg/mL, Sigma-Aldrich, St. Louis, Mo,
USA),and0.1%amphotericin-B (250μg/mL,Sigma-Aldrich,
St. Louis, MO). The glucose concentration within this
medium was made to be 25.0mM by adding D-glucose
(4912, Mallinckrodt, Phillipsburg, NJ, USA). MSCs were
seeded in either 6-well or 24-well plates (BD Biosciences,
San Jose, Calif, USA) at a density of 1.5×104/cm2.T h e6 -
well plates were used to measure samples for the metabolic
assays, and the 24-well plates were used to acquire cell
number at various days throughout the experiment. At
this density, the cells were nearly conﬂuent upon seeding,
in order to minimize cell proliferation over the course
of the experiment. Upon seeding the cells, wells in the
6-well and 24-well plates were ﬁlled with 2.4mL and 0.5mL
of maintenance medium respectively so that the medium
height would be the same between the two plate types. The
cells were allowed to attach and stabilize for twelve hours
after seeding. The immediate conclusion of this twelve-hour
period corresponds to “day 0.” The study lasted a total of
six days. Twelve experimental medium groups were used in
this portion of the study corresponding to twelve glucose
concentration (0.5mM, 1.0mM, 5.0mM, and 25.0mM)
and serum concentration (2%, 5%, or 10%) combinations.
Twelve samples were accorded to each group, except the
pyruvate groups (please see below). Subsequently, 1.0mL
medium samples were obtained on days 4 and 6 for the
glucose, lactate, and pyruvate analysis. Cell number was
measured on days 0, 2, 4, and 6. Medium was refreshed in
wells that were not analyzed on that particular experimental
day.
2.2. Three-Dimensional Cell Culture. Circular collagen gels
with an area of 2.0cm2 and a height of 0.5mm were
used as three-dimensional scaﬀolds for culturing the MSCs.
Collagen was harvested from porcine tendon and placed in
0.5M acetic acid (Mallinckrodt Baker, Phillipsburg, NJ). The
acid soluble collagen was neutralized with 2.0M sodium
hydroxide (NaOH) (Mallinkrodt Baker, Phillipsburg, NJ).
High-density gels at 5.0mg/mL and low-density gels at
2.5mg/mL were prepared in 24-well plates. Each gel was
formed using 100μL of collagen solutionand each contained
250,000 MSCs. Four experimental groups were used in
this portion of the study corresponding to two glucose
concentration (0.5mM and 25.0mM) and ﬁnal collagen
concentration (2.5mg/mL and 5.0mg/mL) combinations.
Twelve samples were accorded to each group. The serum
concentration for each case was 5%. For each medium
combination, a volume of 0.5mL was used for each well of
the 24-well plates. Subsequently, the medium was collected
on days 4 and 6 for the glucose and lactate characterization.
C e l ln u m b e rw a sm e a s u r e do nd a y s0 ,2 ,4 ,a n d6 .
2.3. Cell Population. The 24-well plates were used for cell
number determination for both two- and three-dimensional
cultures. Brieﬂy, Hoechst dye (Invitrogen, Carlsbad, Calif,
USA) was added to DMEM for a ﬁnal concentration of
5.0μg/mL. A 100μL volume of this Hoechst solution was
added to each well of the 24-well plates. Subsequently,
the plates were placed in a 37◦C, 5% CO2 incubator
for ﬁfteen minutes. Each plate was read in a ﬂuorometer
(Thermo Electron, Finland) using an excitation of 355nm
and the emission was measured at 460nm. Background
measurements were taken using cell-free empty wells for
the two-dimensional culture or cell-free gels for the three-
dimensional culture. The ﬂuorometer readings, in conjunc-
tion with an experimentally determined calibration curve,
were used to calculate the cell population within each well.
2.4. Cell Viability. The same 24-well plates used to assess cell
population were used to observe cell viability qualitatively
using ﬂuorescence imaging. Brieﬂy, both calcein-AM and
ethidium bromide (Fluka, St. Louis, MO) were added to
DMEM for a ﬁnal concentration of 2.5μM. Calcein-AM
indicates living cells by emitting 517nm light when excited
by 494nm light, and ethidium bromide indicates dead cells
by emitting 617nm light when excited by 528nm light.
A 100μL volume of this solution was added to each well of
the 24-well plates. Subsequently, the plates were placed in a
37◦C, 5% CO2 incubator for ﬁfteen minutes. The wells were
observed using the 10X and 40X magniﬁcation objectives on
an IX71 ﬂuorescence microscope (Olympus, Center Valley,
Pa, USA), and TIFF images were taken using a QColor 5
camera (Olympus, Center Valley, PA) and QCapture Pro
version 5.0.1.26 software (QImaging, Surrey, BC, Canada).
The TIFF images were converted to bitmap images using
Irfanview version4.25software(IrfanSkiljan,2009)andwereStem Cells International 3
then merged using Artweaver version 0.3.9.9 software (Boris
Eyrich, 2005).
2.5. Glucose Assay. Medium samples were tested for glucose
concentration using a ﬂuorometric assay kit (Invitrogen,
Carlsbad, CA). The kit indicates the presence of glucose
by activating ﬂuorescent resoruﬁn, which has absorption
maxima at 571nm and emission maxima at 585nm. Samples
were diluted with deionized water so that the glucose
concentration would fall within the optimum detection
range of the kit, between 3.0μM and 50.0μM. Fluorescence
was measured using a ﬂuorometer with excitation at 530nm
and emission detection at 590nm. Background measure-
ments were taken using glucose-free DMEM (Invitrogen,
Carlsbad, CA). The emission values were converted to
glucose concentration using a calibration curve. Then, these
concentrations were multiplied by the dilution factor to
obtain the glucose concentration within each extracellular
sample.Thisresultingconcentrationwassubtractedfromthe
actual starting glucose concentration of the original growth
medium to obtain the glucose consumption.
2.6. Lactate Assay. Medium samples were tested for lac-
tate concentration using a spectrophotometric assay kit
(Instruchemie, The Netherlands). The kit determines the
concentration of lactate by detecting an increase in the
absorbance of reduced nicotinamide adenine dinucleotide
(NAD)at 340nm, indicating theamount oflactate originally
present in the sample. The NAD absorbance at 340nm
was measured with a spectrophotometer (Thermo Electron,
Finland). Extracellular samples were diluted with an equal
amount of deionized water so that the lactate concen-
tration would fall within the optimum detection range
of the kit, between 0.22mM and 13.32mM. Background
measurements for extracellular samples were taken using
ordinary DMEM. These background measurements were
subtracted from their respective absorption measurements.
Background-subtracted measurements were converted to
lactate concentrations using a calibration curve.
2.7. Pyruvate Assay. Extracellular and intracellular samples
were tested for pyruvate concentration using a spectropho-
tometric assay kit (Instruchemie, The Netherlands). The kit
determines the concentration of pyruvate by detecting a
decrease in the absorbance of oxidized nicotinamide adenine
dinucleotide (NAD) at 340nm, indicating the amount of
pyruvate originally present in the sample. The NADH
absorbanceat 340nm was measured with a spectrophotome-
ter (Thermo Electron, Finland). The optimum detection
range of the kit was between 0.011mM and 0.340mM.
Pyruvate measurements were taken using both an
intracellular and extracellular approach. The extracellular
approach was performed in both the two- and three-
dimensional conditions with six samples accorded to each
condition. The extracellular approach consisted of measur-
ing the pyruvate concentration within the same medium
samples used for glucose and lactate measurements. The
intracellular approach was only performed for the two-
dimensional case. Brieﬂy, each well of the 6-well plate
was rinsed twice with PBS after the medium sample was
extracted for extracellular measurements. Next, the cells
were removed from the wells using cell scrapers, 0.5mL
of cold perchloric acid was added to each well, and the
cell/acid solution was placed in microcentrifuge tubes. Next,
the samples were subjected to vortex for thirty seconds,
placed in a −20◦C freezer for ﬁve minutes, and then
centrifuged for ten minutes at 1700 ×g (Beckman Coulter,
Fullerton, CA). The resulting supernatant was used to
assay for pyruvate concentration. The samples did not have
to be diluted in either the extracellular or intracellular
case. Background measurements for intracellular samples
were taken using deionized water samples. Background
measurements for extracellular samples were taken using
ordinary DMEM. These background measurements were
subtracted from their respective absorption measurements.
Background-subtracted measurements were converted to
lactate concentrations using a calibration curve.
2.8. Characterization of the Gel Transport Properties. Viscous
drag coeﬃcients were obtained for trypan blue (Sigma-
Aldrich, St. Louis, MO) diﬀusing through 2.5mg/mL and
5.0mg/mL collagen gels. Clear 1.0cm diameter test tubes
were used to hold 2.0mL of each gel concentration (N = 3
for each concentration). The tubes were then capped and
placed in a 37◦C incubator for two hours. After incubation,
each received 1.0mL of 0.13% trypan blue solution. The
trypan blue solution was allowed to diﬀuse through the
collagen gels while the tubes were maintained at 37◦C. Over
the span of 3days, the tubes were periodically photographed
(CanonEOSRebel Digital EF-S18-55; Tokyo, Japan) and the
images were used to determine the distance that the trypan
blue solution advanced through the gels using QCapture Pro
software (version 5.0.1.26; QImaging; Surrey, BC, Canada).
The process was repeated for a set of trypan blue solutions
in pure water. After all of the data was collected, the trypan
blue advancement was plotted versus time. A second-order
polynomial curve was ﬁt to the data points, and the equation
was used to ﬁnd values for both the velocity and acceleration
of the dye through the gels. A force balance on the trypan
blue molecules was used to estimate values of the drag
coeﬃcient
−ζ ∗ vdrift −ρgelVg+ ρtrypanVg = ρtrypanVa,( 1 )
where ζ is the drag coeﬃcient, vdrift is the drift velocity of
the trypan blue molecules, ρgel is the density of the gel, V
is the volume of the molecule that is diﬀusing through the
matrix, g is the acceleration due to gravity, ρtrypan is the
density of trypan blue powder, and a is the experimentally
determined acceleration of the trypan blue through the
collagen matrix. For these experiments, the values of the
constants in (1) were the following: V was 1.20E − 28 m3,
ρtrypan was 1667kg/m3, ρgel was 1000kg/m3,a n dg was
9.8m/s2. The same values were used to estimate the drag
coeﬃcient for trypan blue in water. Afterward, (1)w a su s e d
to solve for relative drag coeﬃcients consisting of the drag
coeﬃcientsof trypan bluein collagengels normalized to that
oftrypan bluein water. Itis critical tonote that experimental4 Stem Cells International
values for the acceleration of the trypan blue molecule were
much smaller than those of the acceleration due to gravity.
Therefore, the term containing a was negligible in solving
for the relative drag coeﬃcients. Relative diﬀusivity values
were calculatedby taking the reciprocal of the respective drag
coeﬃcients.
2.9. Statistics. StatView version 5.0.1 was used to apply a
one factor analysis of variance (ANOVA) and Tukey-Kramer
post-hoc test to the data to evaluate statistical signiﬁcance
between the groups at a signiﬁcance level of P<. 05.
3.Results
3.1. Cell Population. The cell population at the start of the
two-dimensional experiment was even between the diﬀerent
experimental groups (Figure 1). The population data began
to exhibit signiﬁcant diﬀerences between serum concentra-
tions at day two and between glucose concentrations at day
f o u r .H o w e v e r ,b yd a ys i xs i g n i ﬁ c a n td i ﬀerences between
serum groups were not found. Additionally, higher glu-
cose concentrations produced higher cell populations than
the lower glucose concentrations. The three-dimensional
cell population data did not exhibit signiﬁcant diﬀerences
between the two collagen densities or the two glucose
concentrations (Figure 2). However, of note are the high
standard deviations for most of the data.
3.2. Cell Viability. The two-dimensional, day zero cell via-
bility indicates high cell number and conﬂuency before the
cells were exposed to any experimental treatments (images
not shown). However, by day two the cells in the 0.5mM
and 1.0mM environments exhibited low viability while
those in the 5.0mM and 25.0mM environments exhibited
high viability (Figure 3). This trend continued through
days four and six. For the three-dimensional culture, there
were noticeable diﬀerences in the cell viability between
both the collagen densities and the environmental glucose
concentrations. At day zero, the cell viability and conﬂuency
were higherfor cellsplaced in the 2.5mg/mL collagenmatrix
(images not shown). Once applied, the 0.5mM glucose
environment caused the cells to exhibit low viability and
conﬂuency for the duration of the experiment regardless
of the collagen density (Figure 4). In the 25.0mM glucose
group, cell viability and conﬂuency steadily decreased in the
2.5mg/mL group while viability and conﬂuency increased in
the 5.0mg/mL group (Figure 4).
3.3. Glucose Consumption. In both the two- and three-
dimensional cases, glucose consumption was the highest
in the 25.0mM groups (data not shown). For the two-
dimensional case, there were three cases of signiﬁcant diﬀer-
encesbetweenserumgroupsand a number ofsigniﬁcant dif-
ferencesbetweenglucosegroups.Thethree-dimensional case
didnot yield a signiﬁcant diﬀerencebetweencollagengroups
or glucose groups until day six, when the consumption was
higherforthecellsinthe5.0mg/mLcollagenmatrix than the
cells in the 2.5mg/mL collagen matrix.
3.4. Lactate Production. Groups with higher glucose con-
sumption would be expected to yield higher lactate pro-
duction as the endpoint of glycolysis. This behavior was
showninthelactateproductiondata,withlactateproduction
increasing withincreasing glucoseconsumptioninbothtwo-
and three-dimensional cultures (data not shown). At all FBS
levels on days 4 and 6 the 0.5mM and 1.0mM glucose
groups exhibited signiﬁcantly lower lactate production than
the 15mM group at the P<. 05 level. Similarly, lactate
production mirrored the glucose consumption in three-
dimensional culture for both days four and six. There was
no signiﬁcant eﬀect of FBS on lactate production in the two
dimensional cultures.
3.5. Pyruvate Production. As pyruvate is not likely to
accumulate, being converted to either lactate or acetyl
coenzyme A, the amount of pyruvate produced would
not be expected to have a consistent pattern amongst the
experimental glucose groups. This random behavior was
shown in both the intracellular and extracellular, two-
dimensional culture data, especially in terms of statistical
signiﬁcance (Figure 5). However, the overall pyruvate levels
did decrease as the serum concentration increased in both of
the two-dimensional cases. The pyruvate production levels
in the three-dimensional culture were consistently higher for
the 25.0mM glucose group than the 0.5mM glucose group.
3.6. Metabolic Ratios. Lactate-to-pyruvate ratios for two-
dimensional culture showed an increasing trend with an
increase in the starting glucose concentration, indicating
that higher glucose cultures were more anaerobic (Table 1).
Forthelactate-to-glucoseratiosfortwo-dimensionalculture,
the values within the 2% serum group exhibited a similar
increasing trend with an increase in starting glucose con-
centration (Table 2). However, the values within the 5% and
10% serum groups did not. Of note are the discrepancies
in the actual sample populations when evaluating statistical
signiﬁcance. Many samples showed little to no pyruvate
production, causing calculation of the lactate-to-pyruvate
ratios to become impossible. Additionally, some samples
s h o w e dl i t t l et on og l u c o s ec o n s u m p t i o ni nt h e0 . 5a n d
1.0mM groups, causing lactate-to-glucose ratio calculations
to become impossible as well. This explains why a number
of experimental groups lack the expected twelve samples.
The lactate-to-pyruvate and lactate-to-glucose ratios for the
three-dimensional culture did not show any clear trend
(Table 2).
3.7. Gel Transport Properties. Drift velocities and acceler-
ations indicate that the trypan blue molecules traveled
quicker through the 2.5mg/mL gel than the 5.0mg/mL gel
(Table 3). These characteristics were reﬂected in the mean
drag coeﬃcients, as that of the 5.0mg/mL gel was larger than
that of the 2.5mg/mL gel.
4.Discussion
The overall purpose of this research was to investigate possi-
ble diﬀerences in the metabolic state of MSCs when culturedStem Cells International 5
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Figure 1: Cell population (mean ± standard deviation) over the course of six days while in two-dimensional culture (n = 12 per group).
Higher glucose and serum concentrationsappear to produce higher cell populations over time. (a:signiﬁcance between corresponding value
in the 5% group; b: signiﬁcance between corresponding value in the 10% group; c: signiﬁcance between corresponding values in the 5% and
10% groups; d: signiﬁcantlydiﬀerence between the 5.0 and 25.0mM glucose values within the same serum group; P = .05).
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Figure 2: Cell population (mean ± standard deviation) over the course of six days while in three-dimensional culture (n = 12 per
group). Culturing the cells within the diﬀering three-dimensional environments did not produce any particular trend in the cell population.
Statistical signiﬁcance was not observed at the P = .05 level.6 Stem Cells International
Table 1: Summaryoftwo-dimensionalL/PratiosandL/Gratios.L/Pratiosindicatethatgroups withahigherstartingglucoseconcentration
exhibited a more anaerobic characteristic. This trend was similarin the L/G ratios for the 2% serum group, but not for either the 5% or 10%
serum groups. (a:signiﬁcantlydiﬀerent from corresponding value in the 5.0mg/mL group; b: signiﬁcantlydiﬀerent from the 25.0mM value
within the same collagen group; f: signiﬁcantly diﬀerent from 5.0mM value within same serum group; P = .05).
(a) Two-dimensional lactate-phosphate (L/P) ratios.
Glucose conc. 2% serum 5% serum 10% serum
Mean St. Dev. N Mean St. Dev. N Mean St. Dev. N
Day 4
0.5mM 2.41 2.36 3 2.85 2.92 6 5.92 3.48 3
1.0mM 0.59b 0.93 9 4.77b 4.18 10 5.61 3.02 7
5.0mM 8.79 8.52 12 23.46 17.01 10 52.48 34.08 8
25.0mM 14.98 13.12 12 36.05 34.25 12 50.01 32.62 11
Day 6
0.5mM 0.17 0.34 8 9.57 17.89 4 4.15 4.83 4
1.0mM 10.06 25.28 11 26.58 11.34 6 31.76 37.43 4
5.0mM 51.37 17.22 6 134.35 111.21 8 234.68 549.5 10
25.0mM 71.49 59.71 10 113.18 76.5 12 114.8 152.36 9
(b) Two-dimensional lactate-glucose (L/G) ratios.
Glucose conc. 2% serum 5% serum 10% serum
Mean St. Dev. N Mean St. Dev. N Mean St. Dev. N
Day 4
0.5mM 0.72a 0.45 8 1.47 0.09 6 0.57 0.62 12
1.0mM 0.52 0.55 12 1.81b 1.44 12 2.71 3.65 10
5.0mM 1.19 0.89 12 2.2 1.42 12 2.09 1.44 12
25.0mM 1.53 1.56 12 1.9 1.49 12 2.85 2.67 12
Day 6
0.5mM 0.65f 0.49 9 1.94 2.52 8 0.59 0.63 12
1.0mM 0.47f 0.49 12 3.65 2.6 12 13.53 22.57 9
5.0mM 2.39 1.75 12 2.99 2.29 12 2.69 2.07 12
25.0mM 1.56 1.2 12 1.95 1.45 12 2.32 1.91 12
Table 2: Summaryofthree-dimensionalmetabolicratios.There wasnocleartrend inthedata.(a:signiﬁcantlydiﬀerent from corresponding
value in the 5.0mg/mL group; b: signiﬁcantlydiﬀerent from the 25.0mM value within the same collagen group; P = .05).
Experimental Group L/P Ratio L/G Ratio
Mean St. Dev. N Mean St. Dev. N
Day 4
0.5mM/low density 2.30b 5.66 12 1.93 2.29 6
25.0mM/low density 11.92a 5.41 7 0.92a 0.97 12
0.5mM/high density 2.15b 2.42 12 15.47b 11.20 8
25.0mM/high density 18.73 4.95 6 1.11 0.88 12
Day 6
0.5mM/low density 74.75a,b 77.85 3 17.30a 47.92 12
25.0mM/LowDensity 8.49 9.85 12 2.34 2.44 8
0.5mM/high density 2.92 1.15 6 11.04b 8.60 8
25.0mM/high density 6.32 7.23 12 1.02 1.22 12
Table 3: Summary of results pertaining to trypan blue diﬀusion through collagen gels. The diﬀusivity for both cell densities is roughly the
same. ∗Relative drag coeﬃcient and relative diﬀusivity values were calculated by normalizing against that of water (there was no signiﬁcant
diﬀerence between the diﬀusivity values of the 2.5mg/mL and 5.0mg/mL groups).
Water 2.5mg/mL 5.0mg/mL
Mean Range Mean Range Mean Range
Drift velocity (m/s) 0.04 N/A 2.8E −07 2.5E −07 to 3.0E − 07 2.5E − 07 2.3E −07 to 2.7E −07
Accel. (m/s2)0 . 0 N / A −3.9E − 12 −4.4E −12 to −3.3E −12 −2.6E −12 −2.8E −12 to −2.2E − 12
Relative drag coef.∗ 1.0 N/A 5.9E +04 −1.6E +05t o3.3E +05 2.1E +05 1.8E +05t o2.3E +05
Relative diﬀusivity∗ 1.0 N/A 6.9E −06 6.4E −06 to 7.6E − 06 6.3E − 06 5.8E −06 to 6.7E −06Stem Cells International 7
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Figure 3: Fluorescence microscopy images indicating the viability of BMSCs in two-dimensional culture after the second day (increasing
glucoseconcentrationsfromlefttoright;increasingserumconcentrationsfromtoptobottom).Calcein-AMindicateslivingcells byemitting
green light,whileethidiumbromideindicates deadcells byemittingred light.The0.5mMand1.0mMenvironmentsresulted inlowviability
and sparse cell distribution. The 5.0mM and 25.0mM environments resulted in high viability and the maintenance of high conﬂuency.
Varying the serum concentration did not produce a noticeable diﬀerence in the viability. This result was consistent throughout the course of
the week (20x objective; scale bar represents 250μm).
in ordinary two-dimensional culture versus collagen-based
three-dimensional culture. The two-dimensional experi-
ments consisted of subjecting the cells to various medium
typesthatdiﬀeredinbothglucoseandserumconcentrations.
The three-dimensional experiments subjected cells to two
diﬀerent glucose concentrations and two collagen densities.
The three-dimensional cultureswere only subjected to varia-
tion in glucoseconcentrationas glucoseappeared tohave the
most critical eﬀect on cell growth, viability, and metabolic
state. The 5% serum concentration was chosen because of
its moderation between the 2% and 10% serum groups. The
results highlight relative diﬀerences in the metabolic state
of MSCs when cultured within these diﬀering conditions.
Overall, the two most important factors in aﬀecting the
cell population were starting glucose concentrations and the
addition of a three-dimensional matrix.
This result could have important implications for stem
cell therapies, as diﬀerencesin metabolic state during culture
may aﬀect the terminal diﬀerentiation of the MSCs. Human
adipose-derived stem cells have already shown evidence of
this as their diﬀerentiation into osteogenic cells is altered by
changing their metabolic conditions [52]. As diﬀerentiation
isacomplexprocessundertakenbystemcells,itisreasonable
to assume thatachieving any speciﬁc terminal diﬀerentiation
is dependent upon a signiﬁcant amount of energy use.
Both aerobic metabolism and anaerobic cell metabolism
produce the energy that all cells depend upon to carry out
physiological processes. Furthermore, evidence has shown
that cellsexhibit a preference forone metabolic state overthe
other for speciﬁc processes [50, 51].
Anaerobic glycolysis and the aerobic citric acid cycle are
thetwoprimarymeansforcellstoobtainenergy.Theycanbe
distinguishedbythefateoftheglucoseconsumedbythecells.
In glycolysis, the glucose is converted to pyruvate, which is
then converted to lactate as a dead-end product. However, in
the citric acid cycle, the pyruvate produced at the conclusion
of glycolysis enters into the citric acid cycle in the form of
acetyl coenzyme-A. The relative metabolic state—whether
aerobic or anaerobic—of a cell culture can be assessed after
measuring the glucose consumed and lactate produced; the
higher the amount of lactate, the more likely that the relative
metabolic state anaerobic.
These data elucidate the ability of growth medium
glucoseand serumconcentrationstoalterthemetabolicstate
of the MSCs. It has already been shown that adipose-derived
stem cells from rabbits [53] and humans [52]i n c r e a s e
their lactate production, proliferation, and viability when
exposed to higher glucose environments. The results of this8 Stem Cells International
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Figure 4: Fluorescence microscopy images indicating the viability of BMSCs in three-dimensional culture after the second and sixth days
(increasing glucose concentrations from left to right; increasing collagen densities from top to bottom). Calcein-AM indicates living cells by
emitting green light, while ethidium bromide indicates dead cells by emitting red light. After day 2, the 0.5mM environment resulted in low
viability, while the 25.0mM environment resulted in high viability. By day 6, the 0.5mM environment and the 25.0mM−2.5mg/mL group
resulted in low viability, while the 25.0mM−5.0mg/mL group resulted in high viability and conﬂuency. (40x objective; scale bar represents
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Figure 5: Extracellular pyruvate production after the ﬁnal two days of two-dimensional culture (n = 12 per group). The production data
doesnotshowacleartrend.(a:signiﬁcantlydiﬀerentfromcorrespondingvalueinthe5%group;b:signiﬁcantlydiﬀerentfromcorresponding
value in the 10% group; e: signiﬁcantlydiﬀerent from all other values within sameserum group; f: signiﬁcantlydiﬀerent from 5.0mM value
within sameserum group; g:signiﬁcantlydiﬀerent from 25.0mM value withinsameserum group; h:signiﬁcantlydiﬀerent from the 1.0mM
value within the same serum group; P = .05).
series of experiments correspond well with those outcomes.
The metabolic ratios for the two-dimensional experiments
indicate that both the serum and glucose concentrations
within the growth medium help to determine the cell’s
metabolic state, with higher serum concentrations and
higher glucose concentrations leading to more anaerobic
cultures. The lactate-to-pyruvate ratios indicate that glucose
was more inﬂuential than serum, as increases in the glucose
concentration produced marked increases in the metabolic
ratio that were not replicated by increases in the serum con-
centration.The ratiosforthethree-dimensional experiments
did not show a clear trend across the last two days. But
overall, the lactate-to-pyruvate ratios were much lower for
the three-dimensional culturesthan forthe two-dimensional
cultures, indicating that the three-dimensional cultures were
less anaerobic. While the results of the two dimensional
cultures were expected, the addition of a three dimensional
extracellular matrix had unexpected eﬀects on the L/P and
L/G ratios, suggesting that these eﬀects must be investigated
in much more detail.
The setup of these experiments had several advantages.
The primary advantage was the use of the same cell
type for both two-and three-dimensional culture so as
to avoid potential signiﬁcant diﬀerences in metabolism
between diﬀerent cell types. This reality was highlighted
by Sander and Nauman, as it was found that culturing rat
astrocytesproducedlowerlactate-to-glucoseratiosthanboth
porcine lamina cribrosa cells and porcine scleral ﬁbroblasts
after one week of culture in environments with diﬀerent
glucose and oxygen levels [54]. Additionally, in the case of
the two-dimensional experiment, both glucose and serum
concentrations were varied simultaneously so that the eﬀects
of both medium components could be isolated. The glucose
assay, with a resolution of 3.0μM of D-glucose, the lactate
assay, with a resolution of 0.22mM of lactate, and the
pyruvate assay, with a resolution of 0.011mM, provided
high sensitivity. In the future, studies of this nature will be
supplemented with real-time imaging of NADH within live
cells to estimate the location and intensity of the relative
metabolic activity within the cells.
These experiments also possessed a number of limita-
tions. The purpose of the trypan blue diﬀusion experiments
was to investigate the possibility that the metabolites were
trapped within the collagen matrix, thus avoiding detection
by the assays. However, trypan blue—molecular weight
of ∼960g/mol—was able to seep approximately 1.0mm
through both the 2.5mg/mL and 5.0mg/mL collagen gels
in about ﬁfteen minutes (data not shown). Therefore, it is
reasonable to assume that glucose, lactate, and pyruvate—
all with molecular weights of less than 200g/mol—were able
to traverse the collagen matrix and be subject to detection.
There are two other circumstances that indicate that the
thickness of the gels did not prevent adequate transport
of lactate out of the gels. The ﬁrst is the recognition that
calcein-AM—molecular weight ∼995g/mol—did not have
any trouble diﬀu s i n gi n t ot h eg e lw i t h i nﬁ f t e e nm i n u t e si n
order to take ﬂuorescence images of the cells. The second
comesfromthe result ofthe nutrient supplystudy by Horner
and Urban [55]. In this study, the researchers embedded
nucleus cells within a 1% agarose matrix and monitored
the cells’ viability as a function of their distance away from
the nutrient supply within a diﬀusion chamber. Homer and
Urban showed that the embedded cells were still viable
within 5.0mm of the nutrient supply. However, there is
uncertainty as to the similarity of diﬀusive and mechanical
properties between the 1% agarose gels and the collagen gels
of this study. Another disadvantage was that constriction of
the collagen gels could not be prevented during the course of
theweek longexperiments, withmost ofthe gelsconstricting
to about 75% of their original size. This may especially be
reﬂected in the cell viability images, in which higher cell
death is seen in the 2.5mg/mL samples rather than the
5.0mg/mL samples by the time the experiment concluded.
It is likely that the stiﬀer gels attenuated the degree of
constriction, giving the cells better access to nutrient/waste
transport through the matrix during the course of the week.
Theresultsofthisseriesofexperimentsserveasabaseline
characterization of MSCs in culture before being subjected
to either an extracellular matrix or a diﬀerentiation scheme,
and theywill be especially beneﬁcialto thetissue engineering10 Stem Cells International
ﬁeld. While it is well documented that extracellular matrices
have signiﬁcant eﬀects on several cell types [56–59], the
eﬀectof extracellular matrices on cell metabolism have yet to
be investigated. Because cell metabolism is altered in three-
dimensional culture when compared to two-dimensional
culture, this could have signiﬁcant implications on the use
of extracellular matrices because cell metabolism aﬀects all
of cellular physiology. Therefore, a future study on the eﬀect
of cell metabolism on stem cell terminal diﬀerentiation is
imperative. Additionally, it will be equally important to
perform a study investigating diﬀerences in cell metabolism
versus the type of extracellular matrix material used. Herein,
we demonstrated that glucose is the dominant factor aﬀect-
ing cell metabolism, but FBS also modulates this eﬀect, and
thelong-termeﬀectsofcultureconditionsonphenotypeand
phenotypicpotentialmuststill beelucidated.Itisanticipated
that FBS availability may play a more important role in
diﬀerentiation, and it is possible that the protein content
of the FBS could play a role in coupling the metabolic and
diﬀerentiation pathways.
While, there is always great risk associated with tran-
sitioning from in vitro to in vivo studies because the
environments are diﬀerent in many ways, from practical
and ethical standpoints, it would be advantageous to have
a means of investigating a set of experimental variables on
an artiﬁcial tissue analogue prior to implementing the same
variables in an animal system; this intermediate step could
accelerate research ﬁndings and prevent the unnecessary
deaths of the animals should the results from this in vitro
tissue reveal dangerous eﬀects that the two-dimensional case
alone did not reveal. Consequently, this intermediate step
could potentially decrease costs associated with in vitro-to-
in vivo experimentation.
5.Conclusions
The results of this study indicate that the amount of glucose
provided and the presence of an extracellular matrix do
indeed aﬀect the metabolic state and viability of cells in
culture. Providing larger concentrations of glucose may be
a way to push the cells toward the anaerobic state, all else
being equal. Additionally, the results demonstrated that the
three-dimensional culture of MSCs may have to take place
within a relatively stiﬀ matrix or a composite of collagen
hydrogel and collagen ﬁbers [60, 61]t op r e v e n td e c r e a s e s
in cell viability, and further work is needed to elucidate
the eﬀects of extracellular matrix on MSC metabolism.
Diﬀusionresultsshowthattheoveralltransport propertiesof
two high-density collagen gels were essentially the same, so
that diﬀerences in the results between experimental groups
in three-dimensional culture could not be attributed to
diﬀerences in transport properties. Further investigation
is required to elucidate the eﬀects of metabolic state on
phenotype and phenotypic potential.
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